Calciphylaxis
Rare syndrome of painful skin lesions from small vessel calcification.
Calciphylaxis, sometimes called calcific uremic arteriolopathy (CUA) or “Grey Scale,” is an uncommon condition marked by intensely painful skin sores. Exactly what causes it isn’t fully understood, but the process is thought to involve calcium deposits building up in the tiny blood vessels within fat tissue and deeper skin layers, followed by blood clots and the death of skin cells from lack of oxygen. Most people who develop it have end-stage kidney disease, though it can also appear in earlier stages of chronic kidney disease and, very rarely, in individuals with healthy kidneys. It’s a serious but infrequent problem, estimated to affect 1 to 4 percent of all dialysis patients. The wounds it causes are chronic and don’t heal well, and the outlook is poor—typical survival is less than a year.
This condition is a form of extraskeletal calcification, similar to what’s seen in some people with high blood calcium from conditions like milk-alkali syndrome, sarcoidosis, primary hyperparathyroidism, or too much vitamin D. In rare instances, medications such as warfarin can also trigger it.
**Signs and symptoms** The earliest skin changes are a mottled appearance and firmness in a pattern called livedo reticularis. As tissue clots and dies, a black, leathery scab forms over an ulcer with a dark, stuck-on slough. Around these ulcers, the skin often feels hard and plate-like. The sores are always extremely painful and most commonly show up on the lower legs, belly, buttocks, or penis. They tend to appear in multiple spots on both sides of the body. Because the tissue has died, healing is rare, and the ulcers frequently get infected. Many cases lead to a widespread bacterial infection and death.
Under the microscope, calciphylaxis shows two key features: widespread calcium deposits in the middle layer of artery walls (medial calcification), and—unlike other types of vascular calcification—calcification in the walls of small blood vessels, sometimes with internal scarring, calcium outside the vessels, and blood clots that cut off blood flow to the skin, causing it to die.
**Heart of stone** In severe cases, calcium buildup in the heart muscle can prevent the ventricles from filling properly during diastole, leading to diastolic heart failure. This condition is sometimes called “heart of stone.”
**Cause** The exact cause isn’t known, and it’s not an allergic reacti
- field
- Medicine (nephrology, dermatology)
- known_for
- Rare syndrome of painful skin lesions due to small vessel calcification, primarily in dialysis patients
- affected_population
- 1-4% of dialysis patients
- typical_life_expectancy
- Less than one year
- common_sites
- Lower extremities, abdomen, buttocks, penis
Lore & Background
Calciphylaxis is a rare but serious disease, believed to affect 1-4% of all dialysis patients. It results in chronic non-healing wounds and indicates poor prognosis, with typical life expectancy of less than one year. The first skin changes are mottling of the skin and induration in a livedo reticularis pattern, progressing to black, leathery eschar and ulcers that are extremely painful. Lesions are often multiple and bilateral, and wound healing seldom occurs due to tissue infarction.
Reader's Guide
Calciphylaxis is significant as a severe complication of end-stage kidney disease, with a high mortality rate and limited treatment options. The disease involves systemic medial calcification of arteries and small vessel mural calcification leading to tissue ischemia and necrosis. Diagnosis is clinical, supported by skin biopsy showing arterial calcification and occlusion without vasculitis. Treatment requires a multidisciplinary approach including pain management, wound care, risk factor mitigation (e.g., increasing dialysis, parathyroidectomy), and pharmacotherapy such as sodium thiosulfate or bisphosphonates. The cause remains unknown, but hypotheses include abnormal calcium-phosphate homeostasis, vitamin K deficiency, and adipocyte-mediated calcification. Reported risk factors include female sex, obesity, warfarin use, and diabetes mellitus.
Did You Know?
- Calciphylaxis is also known as calcific uremic arteriolopathy (CUA) or 'Grey Scale'.
- Severe forms may cause diastolic heart failure from cardiac calcification, called 'heart of stone'.
- Warfarin, a vitamin K antagonist, is a reported risk factor for calciphylaxis.
- Sodium thiosulfate is commonly prescribed for treatment, though its mechanism is unknown.
Frequently Asked Questions
Who is Calciphylaxis?
Calciphylaxis, nicknamed 'Grey Scale' or calcific uremic arteriolopathy, is a rare and devastating condition in which calcium builds up inside the tiny vessels of fat and deeper skin, triggering clots and tissue death. It most often strikes people living with end-stage kidney disease on dialysis, though it can occasionally surface in earlier kidney disease or, very rarely, in those with healthy kidneys.
What are Calciphylaxis's powers/role?
Its signature 'power' is to produce excruciatingly painful, non-healing skin sores by choking off oxygen to small vessels, causing the overlying tissue to die. The precise upstream trigger is still not fully understood, but the hallmark sequence is arteriolar calcification, thrombosis, and ischemic necrosis.
How does Calciphylaxis's story end?
The prognosis is sobering: median survival from diagnosis is frequently cited as under one year, making it one of the deadliest complications in nephrology. There is no single curative intervention; care centers on aggressive pain management, meticulous wound care, correcting calcium-phosphate balance, and experimental options such as bisphosphonates or hyperbaric oxygen.
Why is Calciphylaxis important?
It affects roughly one to four percent of dialysis patients and carries a mortality rate that makes it a critical concern at the crossroads of nephrology and dermatology. Because its root pathophysiology remains incompletely mapped, it represents both a major unmet clinical need and an active area of research.
Where does Calciphylaxis appear?
Lesions most commonly erupt on the lower legs, abdomen, buttocks, and—in men—the penis, all regions rich in subcutaneous fat. They typically begin as mottled, intensely tender patches that progress to dark, necrotic ulcers with a characteristic grey-to-black discoloration.
More in Ailments of unknown cause 1-24
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record